11.12.2009 • News

GxP Announces New Expansion Strategy

Mark Stevens, Managing Director of GxP Consulting
Mark Stevens, Managing Director of GxP Consulting

GxP Consulting, a leading provider of compliance services to the pharmaceutical and biopharmaceutical ­industries announced expansion plans in the U.S. and UK markets. Led by Mark Stevens, managing director at GxP Consulting, the company has launched a strategy to expand services and support to customers in Europe and America in order to help businesses rise to the challenges currently being faced across the industry.
As part of this expansion, GxP Consulting announces a strategic new facility in Irvine, California, to support increased activity in North America. Secondly, expansion in the UK has led GxP Consulting to move its headquarters into a new larger purpose-built facility in Nottingham.
Mark Stevens, Managing Director of GxP Consulting will be spearheading the drive for growth and he brings with him expertise, experience and a world-class team of consultants.
Mark comments: "This is an ­exciting time for GxP Consulting. We ­recently marked our ten year anniversary, which is a significant milestone for any business and the next step for us is to push forward with our expansion strategy across both the USA and UK."

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.